Michael Policar, MD MPH

NPI: 1437104197
Total Payments
$40,331
2024 Payments
$50.28
Companies
5
Transactions
40

Payment Breakdown by Category

Consulting$35,100 (87.0%)
Travel$4,800 (11.9%)
Food & Beverage$431.75 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $35,100 14 87.0%
Travel and Lodging $4,800 11 11.9%
Food and Beverage $431.75 15 1.1%

Top Paying Companies

Company Total Records Latest Year
Sebela Pharmaceuticals Inc. $39,900 25 $0 (2019)
Organon Llc $258.00 7 $0 (2024)
Merck Sharp & Dohme Corporation $97.17 5 $0 (2019)
Allergan Inc. $67.08 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $50.28 1 Organon Llc ($50.28)
2023 $156.48 4 Organon LLC ($146.98)
2022 $60.74 3 Organon LLC ($60.74)
2019 $28,596 24 Sebela Pharmaceuticals Inc. ($28,550)
2018 $11,371 4 Sebela Pharmaceuticals Inc. ($11,350)
2017 $97.37 4 Merck Sharp & Dohme Corporation ($52.27)

All Payment Transactions

40 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/27/2024 Organon Llc Food and Beverage In-kind items and services $50.28 General
12/07/2023 Organon LLC Food and Beverage In-kind items and services $53.48 General
02/09/2023 Organon LLC Food and Beverage In-kind items and services $56.15 General
02/09/2023 Organon LLC Food and Beverage In-kind items and services $37.35 General
01/20/2023 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $9.50 General
08/10/2022 Organon LLC Food and Beverage In-kind items and services $21.89 General
08/10/2022 Organon LLC Food and Beverage In-kind items and services $21.88 General
05/07/2022 Organon LLC NEXPLANON (Drug) Food and Beverage In-kind items and services $16.97 General
Category: ETONOGESTREL
07/23/2019 Merck Sharp & Dohme Corporation NEXPLANON (Drug) Food and Beverage In-kind items and services $24.11 General
Category: WOMENS HEALTH
05/31/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
05/31/2019 Sebela Pharmaceuticals Inc. Travel and Lodging Cash or cash equivalent $516.27 General
05/03/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
05/03/2019 Sebela Pharmaceuticals Inc. Travel and Lodging Cash or cash equivalent $536.99 General
04/05/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
04/05/2019 Sebela Pharmaceuticals Inc. Travel and Lodging Cash or cash equivalent $84.36 General
03/22/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $1,250.00 General
03/22/2019 Sebela Pharmaceuticals Inc. Travel and Lodging Cash or cash equivalent $87.14 General
02/22/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
02/22/2019 Sebela Pharmaceuticals Inc. Travel and Lodging Cash or cash equivalent $809.03 General
02/04/2019 Allergan Inc. LILETTA (Drug) Food and Beverage In-kind items and services $21.98 General
Category: WOMENS HEALTH
01/11/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
01/11/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
01/11/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
01/11/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
01/11/2019 Sebela Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $1,250.00 General

About Michael Policar, MD MPH

Michael Policar, MD MPH is a Obstetrics & Gynecology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437104197.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Policar, MD MPH has received a total of $40,331 in payments from pharmaceutical and medical device companies, with $50.28 received in 2024. These payments were reported across 40 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($35,100).

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location San Francisco, CA
  • Active Since 05/23/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1437104197

Products in Payments

  • NEXPLANON (Drug) $41.08
  • NUVARING (Drug) $29.04
  • LILETTA (Drug) $21.98

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in San Francisco